Attached files
file | filename |
---|---|
EX-32.2 - VLL8 INC 10-Q 093017 EXHIBIT 32.2 - Venture Lending & Leasing VIII, Inc. | vll810q093017ex322.htm |
EX-32.1 - VLL8 INC 10-Q 093017 EXHIBIT 32.1 - Venture Lending & Leasing VIII, Inc. | vll810q093017ex321.htm |
EX-31.2 - VLL8 INC 10-Q 093017 EXHIBIT 31.2 - Venture Lending & Leasing VIII, Inc. | vll810q093017ex312.htm |
EX-31.1 - VLL8 INC 10-Q 093017 EXHIBIT 31.1 - Venture Lending & Leasing VIII, Inc. | vll810q093017ex311.htm |
FORM 10-Q
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
[X] | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2017
[ ] | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from ___________ to ______________
Commission file number 814-01162
Venture Lending & Leasing VIII, Inc.
(Exact Name of Registrant as specified in its charter)
Maryland | 47-3919702 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
104 La Mesa Drive, Suite 102, Portola Valley, CA | 94028 |
(Address of principal executive offices) | (Zip Code) |
(650) 234-4300
(Registrant's telephone number, including area code)
Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [x] No [ ]
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X] No [ ]
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of “large accelerated filer”, “accelerated filer”, and "smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer [ ] | Accelerated filer [ ] | Non-accelerated filer [x] | Smaller reporting company [ ] |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes [ ] No [x]
Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date:
Class | Outstanding as of November 13, 2017 | |
Common Stock, $.001 par value | 100,000 |
VENTURE LENDING & LEASING VIII, INC.
INDEX
PART I — FINANCIAL INFORMATION | |
Item 1. | Financial Statements |
Condensed Statements of Assets and Liabilities (Unaudited) | |
As of September 30, 2017 and December 31, 2016 | |
Condensed Statements of Operations (Unaudited) | |
For the three and nine months ended September 30, 2017 and 2016 | |
Condensed Statements of Changes in Net Assets (Unaudited) | |
For the nine months ended September 30, 2017 and 2016 | |
Condensed Statements of Cash Flows (Unaudited) | |
For the nine months ended September 30, 2017 and 2016 | |
Notes to Condensed Financial Statements (Unaudited) | |
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations |
Item 3. | Quantitative and Qualitative Disclosures About Market Risk |
Item 4. | Controls and Procedures |
PART II — OTHER INFORMATION | |
Item 1. | Legal Proceedings |
Item 1A. | Risk Factors |
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds |
Item 3. | Defaults Upon Senior Securities |
Item 4. | Mine Safety Issues |
Item 5. | Other Information |
Item 6. | Exhibits |
SIGNATURES |
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements
VENTURE LENDING & LEASING VIII, INC.
CONDENSED STATEMENTS OF ASSETS AND LIABILITIES (UNAUDITED)
AS OF SEPTEMBER 30, 2017 AND DECEMBER 31, 2016
September 30, 2017 | December 31, 2016 | ||||||
ASSETS | |||||||
Loans, at estimated fair value | |||||||
(Cost of $288,624,300 and $128,866,570) | $ | 286,352,699 | $ | 125,550,657 | |||
Interest Rate Cap (Cost of $80,529 and $57,806) | 45,901 | 117,849 | |||||
Total Investments (Cost of $288,704,829 and $128,924,376) | 286,398,600 | 125,668,506 | |||||
Cash and cash equivalents | 15,353,728 | 9,821,733 | |||||
Other Assets | 6,164,954 | 2,423,464 | |||||
Total assets | 307,917,282 | 137,913,703 | |||||
LIABILITIES | |||||||
Borrowings under debt facility | 113,000,000 | 53,000,000 | |||||
Accrued management fees | 2,251,397 | 2,647,656 | |||||
Accounts payable and other accrued liabilities | 1,329,141 | 1,194,405 | |||||
Total liabilities | 116,580,538 | 56,842,061 | |||||
NET ASSETS | $ | 191,336,744 | $ | 81,071,642 | |||
Analysis of Net Assets: | |||||||
Capital paid in on shares of capital stock | $ | 213,075,000 | $ | 97,925,000 | |||
Unrealized depreciation on investments | (2,306,227 | ) | (3,255,870 | ) | |||
Distribution in excess of net investment income | (19,432,029 | ) | (13,597,488 | ) | |||
Net assets (equivalent to $1,913.37 and $810.72 per share based on 100,000 shares of capital stock outstanding - See Note 6) | $ | 191,336,744 | $ | 81,071,642 | |||
Commitments & Contingent Liabilities: | |||||||
Unfunded unexpired commitments (See Note 4) | $ | 75,110,000 | $ | 53,437,500 |
See notes to condensed financial statements
3
VENTURE LENDING & LEASING VIII, INC.
CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED)
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2017 AND 2016
For the Three Months Ended September 30, 2017 | For the Three Months Ended September 30, 2016 | For the Nine Months Ended September 30, 2017 | For the Nine Months Ended September 30, 2016 | ||||||||||||
INVESTMENT INCOME: | |||||||||||||||
Interest on loans | $ | 9,871,413 | $ | 3,309,737 | $ | 23,604,185 | $ | 7,524,776 | |||||||
Other interest and other income | 137,663 | 27,065 | 194,080 | 132,563 | |||||||||||
Total investment income | 10,009,076 | 3,336,802 | 23,798,265 | 7,657,339 | |||||||||||
EXPENSES: | |||||||||||||||
Management fees | 2,251,397 | 2,647,656 | 7,546,709 | 7,942,968 | |||||||||||
Interest expense | 1,323,246 | 492,293 | 3,145,450 | 850,458 | |||||||||||
Banking and professional fees | 49,078 | 55,462 | 206,424 | 192,682 | |||||||||||
Other operating expenses | 45,361 | 32,877 | 390,192 | 82,996 | |||||||||||
Total expenses | 3,669,082 | 3,228,288 | 11,288,775 | 9,069,104 | |||||||||||
Net investment income (loss) | 6,339,994 | 108,514 | 12,509,490 | (1,411,765 | ) | ||||||||||
Net realized loss from investments | (532,458 | ) | — | (3,771,479 | ) | — | |||||||||
Net change in unrealized gain (loss) from investments | (35,780 | ) | (2,099,506 | ) | 949,642 | (2,099,506 | ) | ||||||||
Net realized and change in unrealized loss from investments | (568,238 | ) | (2,099,506 | ) | (2,821,837 | ) | (2,099,506 | ) | |||||||
Net increase (decrease) in net assets resulting from operations | $ | 5,771,756 | $ | (1,990,992 | ) | $ | 9,687,653 | $ | (3,511,271 | ) | |||||
Net increase (decrease) in net assets resulting from operations per share | $ | 57.72 | $ | (19.91 | ) | $ | 96.88 | $ | (35.11 | ) | |||||
Weighted average shares outstanding | 100,000 | 100,000 | 100,000 | 100,000 |
See notes to condensed financial statements
4
VENTURE LENDING & LEASING VIII, INC.
CONDENSED STATEMENTS OF CHANGES IN NET ASSETS (UNAUDITED)
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2017 AND 2016
For the Nine Months Ended September 30, 2017 | For the Nine Months Ended September 30, 2016 | ||||||
Net increase (decrease) in net assets resulting from operations: | |||||||
Net investment income gain (loss) | $ | 12,509,490 | $ | (1,411,765 | ) | ||
Net realized loss from investments | (3,771,479 | ) | — | ||||
Net change in unrealized gain (loss) from investments | 949,642 | (2,099,506 | ) | ||||
Net increase (decrease) in net assets resulting from operations | 9,687,653 | (3,511,271 | ) | ||||
Distributions of income to shareholder | (8,738,010 | ) | — | ||||
Return of capital to shareholder | (5,834,541 | ) | (5,164,338 | ) | |||
Contributions from shareholder | 115,150,000 | 39,900,000 | |||||
Net increase in capital transactions | 100,577,449 | 34,735,662 | |||||
Total increase in net assets | 110,265,102 | 31,224,391 | |||||
Net assets | |||||||
Beginning of period | 81,071,642 | 32,058,748 | |||||
End of period (undistributed net investment income of $0 and $0) | $ | 191,336,744 | $ | 63,283,139 |
See notes to condensed financial statements
5
VENTURE LENDING & LEASING VIII, INC.
CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2017 AND 2016
For the Nine Months Ended September 30, 2017 | For the Nine Months Ended September 30, 2016 | ||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||
Net increase (decrease) in net assets resulting from operations | $ | 9,687,653 | $ | (3,511,271 | ) | ||
Adjustments to reconcile net decrease in net assets resulting from operations to net cash used in operating activities: | |||||||
Net realized loss from investments | 3,771,479 | — | |||||
Net change in unrealized gain (loss) from investments | (949,642 | ) | 2,099,506 | ||||
Amortization of deferred costs related to borrowing facility and interest rate cap agreements | 287,863 | 276,440 | |||||
Net increase in other assets | (2,854,304 | ) | (888,988 | ) | |||
Net increase (decrease) in accounts payable, other accrued liabilities, and accrued management fees | (261,523 | ) | 618,513 | ||||
Origination of loans | (209,767,500 | ) | (77,777,273 | ) | |||
Principal payments on loans | 46,020,386 | 6,590,614 | |||||
Acquisition of equity securities | (14,354,646 | ) | (5,146,571 | ) | |||
Net cash used in operating activities | (168,420,234 | ) | (77,739,030 | ) | |||
CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||
Contributions from shareholder | 115,150,000 | 39,900,000 | |||||
Borrowings under debt facility | 108,350,000 | 44,000,000 | |||||
Investment in Interest rate cap | (49,400 | ) | (30,000 | ) | |||
Repayment of debt facility | (48,350,000 | ) | — | ||||
Payment of bank facility fees and costs | (1,148,371 | ) | (1,111,821 | ) | |||
Net cash provided by financing activities | 173,952,229 | 82,758,179 | |||||
Net increase in cash and cash equivalents | 5,531,995 | 5,019,149 | |||||
CASH AND CASH EQUIVALENTS: | |||||||
Beginning of period | 9,821,733 | 8,335,707 | |||||
End of period | $ | 15,353,728 | $ | 13,354,856 | |||
SUPPLEMENTAL DISCLOSURES: | |||||||
CASH PAID DURING THE PERIOD: | |||||||
Interest | $ | 2,807,074 | $ | 314,785 | |||
NON-CASH OPERATING AND FINANCING ACTIVITIES: | |||||||
Distributions of equity securities to shareholder | $ | 14,572,551 | $ | 5,164,338 | |||
Receipt of equity securities as repayment of loans | $ | 217,905 | $ | 17,767 |
See notes to condensed financial statements
6
VENTURE LENDING & LEASING VIII, INC.
NOTES TO CONDENSED FINANCIAL STATEMENTS (UNAUDITED)
1. | ORGANIZATION AND OPERATIONS OF THE FUND |
Venture Lending & Leasing VIII, Inc. (the “Fund”), was incorporated in Maryland on May 6, 2015 as a non-diversified closed-end management investment company electing status as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (“1940 Act”) and is managed by Westech Investment Advisors, LLC, (“Manager” or “Management”). The Fund will be dissolved on December 31, 2025 unless an election is made to dissolve earlier by the Board of Directors of the Fund (the “Board”). One hundred percent of the stock of the Fund is held by Venture Lending & Leasing VIII, LLC (the “Company”). Prior to commencing its operations on August 12, 2015, the Fund had no operations other than the sale to the Company of 100,000 shares of common stock, $0.001 par value for $25,000 in July 2015. This issuance of stock was a requirement to apply for a finance lender’s license from the California Commissioner of Corporations, which was obtained on August 20, 2015.
The Fund’s investment objective is to achieve a superior risk adjusted return. In the Manager’s opinion, the accompanying condensed interim financial statements (hereafter referred to as “financial statements”) include all adjustments (consisting only of normal recurring adjustments) necessary for a fair presentation of financial position and results of operations for interim periods. Certain information and note disclosures normally included in audited annual financial statements prepared in accordance with Generally Accepted Accounting Principles in the United States of America (“GAAP”) have been omitted; however, the Fund believes that the disclosures made are adequate to make the information presented not misleading. The interim results for the nine months ended September 30, 2017 are not necessarily indicative of what the results would be for a full year. These financial statements should be read in conjunction with the financial statements and the notes included in the Fund’s Annual Report on Form 10-K for the period ended December 31, 2016.
2. | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
Basis of Accounting
The preparation of financial statements in conformity with GAAP requires Management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Certain reclassifications have been made to prior period financial information to conform to the current period presentation.
Cash and Cash Equivalents
Cash and cash equivalents consist of cash on hand and cash equivalents with maturities of 90 days or less. Included in this are money market mutual funds that are valued at their most recently traded price prior to the valuation date. Within cash and cash equivalents, as of September 30, 2017, the Fund held 15,353,728 units in the Blackrock Treasury Trust Institutional Fund at $1 per unit at a yield of 0.91%, which represents 8.02% of the net assets of the Fund.
Interest Income
Interest income on loans is recognized on an accrual basis using the effective interest method including amounts from the amortization of discounts attributable to equity securities received as part of the loan transaction. Additionally, fees received as part of the transaction are added to the loan discount and amortized over the life of the loan.
7
Investment Valuation Procedures
The Fund accounts for loans at fair value in accordance with the “Valuation Methods” below. All valuations are determined under the direction of the Manager, in accordance with the valuation methods.
The Fund’s loans are valued coincident with the issuance of its periodic financial statements, the issuance or repurchase of the Fund’s shares at a price equivalent to the current net asset value per share, and at such other times as required by law. On a quarterly basis, Management submits to the Board a “Valuation Report” and “Valuation Notes”, which details the rationale for the valuation of investments.
As of September 30, 2017 and December 31, 2016, the financial statements include nonmarketable investments of $286.4 million and $125.6 million, respectively (or approximately 93% and 91% of total assets, respectively), with fair values determined by the Manager in the absence of readily determinable market values. Because of the inherent uncertainty of these valuations, estimated fair values of such investments may differ significantly from the values that would have been used had a ready market for the securities existed, and the differences could be material. Below is the information used by the Manager in making these estimates.
Loans
The Fund defines fair value as the price that would be received to sell an asset or paid to lower a liability in an orderly transaction between market participants at the measurement date. Because there is no secondary market for the venture loans made by the Fund to borrowers, Management determines fair value based on hypothetical markets, and on several factors related to each borrower, including, but not limited to the borrower’s payment history, available cash and “burn rate,” revenues, net income or loss, the likelihood that the borrower will be able to secure additional financing in the future, as well as an evaluation of the general interest rate environment. The amount of any valuation adjustment considers liquidation analysis and is determined based upon a credit analysis of the borrower and an analysis of the expected recovery from the borrower, including consideration of factors such as the nature and quality of the Fund’s security interests in collateral, the estimated value of the Fund’s collateral, the size of the loan, and the estimated time that will elapse before the Fund achieves a recovery. Management has evaluated these factors and has concluded that together, the effect of deterioration in the quality of the underlying collateral, increase in size of loan, increase in the estimated time to recovery, and increase in the hypothetical market coupon rate would have the effect of lowering the value of the current portfolio of loans.
Non-accrual Loans
The Fund’s policy is to place a loan on non-accrual status when the portfolio company is three months delinquent on monthly loan payments, or either ceases or drastically curtails its operations and Management concludes that it is unlikely that the loan will return to performing status. When a loan is placed on non-accrual status, all interest previously accrued but not collected for the quarter is reversed. Any uncollected interest related to quarters prior to when the loan was placed on non-accrual status is added to the principal balance, and the aggregate balance of the principal and interest is evaluated in accordance with the policy for valuation of loans in determining Management’s best estimate of fair value. Interest received by the Fund on non-accrual loans will be recognized as interest income if, and when the proceeds received exceeds the book value of the loans.
If a borrower of a non-accrual loan resumes making regular payments and Management believes that such borrower has regained the ability to service the loan on a sustainable basis, the loan is reclassified back to accrual or performing status. Interest that would have been accrued during the non-accrual status will be added back to the remaining payment schedule causing a change in the effective interest rate.
As of September 30, 2017, loans with a cost basis of $4.7 million and a fair value of $2.7 million have been classified as non-accrual. As of December 31, 2016, loans with a cost basis of $4.6 million and fair value of $1.3 million were classified as non-accrual.
8
Warrants and Equity Securities
Warrants and equity securities that are received in connection with loan transactions will be assigned a fair value at the time of acquisition. Warrants are valued based on a modified Black-Scholes option pricing model which considers among several factors, the underlying stock value, expected term, volatility, and the risk-free interest rate. It is anticipated that such securities, will be distributed by the Fund to the Company simultaneously with, or shortly following, their acquisition.
The underlying asset value is estimated based on information available, including information regarding recent rounds of funding of the portfolio company, or the publicly-quoted stock price at the end of the financial reporting period for warrants for comparable publicly-quoted securities.
Volatility, or the amount of uncertainty or risk about the size of the changes in the warrant price, is based on an index of publicly traded companies grouped by industry and which are similar in nature to the underlying portfolio companies issuing the warrant (“Industry Index”). The volatility assumption for each Industry Index is based on the average volatility for individual public companies within the portfolio company’s industry for a period approximating the expected life of the warrants. A hypothetical increase in the volatility of the warrants used in the modified Black-Scholes option pricing model would have the effect of increasing the value of the warrants.
The remaining expected lives of warrants are based on historical experience of the average life of the warrants, as warrants are often exercised in the event of acquisitions, mergers, or initial public offerings and terminated due to events such as bankruptcies, restructuring activities, or additional financings. These events cause the expected term to be less than the remaining contractual term of the warrants. For the nine months ended September 30, 2017, and 2016, the Fund assumed the average duration of a warrant is 3.5 years. The effect of a hypothetical increase in the estimated initial term of the warrants used in the modified Black-Scholes option pricing model would have the effect of increasing the value of the warrants.
The risk-free interest rate is derived from the constant maturity tables issued by the U.S. Treasury Department. The effect of a hypothetical increase in the estimated risk-free rate used in the modified Black-Scholes option pricing model would have the effect of increasing the value of the warrants.
The Fund engages an independent valuation company to provide valuation assistance with respect to the warrants received as part of loan consideration, including an evaluation of the Fund’s valuation methodology and the reasonableness of the assumptions used from the perspective of a market participant. The independent valuation company also calculates several of the inputs used, such as volatility and risk-free rate.
Other Assets and Liabilities
Other Assets include costs incurred in conjunction with borrowings under the Fund’s debt facility and are stated at initial cost. Those costs are capitalized and then amortized over the term of the facility.
As of September 30, 2017 and December 31, 2016, the fair values of Other Assets and Liabilities are estimated at their carrying values because of the short-term nature of these assets or liabilities.
As of September 30, 2017 and December 31, 2016, based on borrowing rates available to the Fund, the estimated fair values of the borrowings under the debt facility were $113.0 million and $53.0 million, respectively.
9
Commitment Fees
Unearned income and commitment fees on loans are recognized in interest on loans using the effective interest method over the term of the loan. Commitment fees are carried as liabilities when received for commitments upon which no draws have been made. When the first draw is made, the fee is treated as unearned income and is recognized as described above. If a draw is never made, the forfeited commitment fee less any applicable legal costs becomes recognized as other income after the commitment expires.
Deferred Bank Fees
The deferred bank fees and costs associated with the debt facility are included in Other Assets in the Condensed Statement of Assets & Liabilities and are being amortized over the estimated life of the facility, which currently matures on September 11, 2020. The amortization of these costs is recorded as interest expense in the Condensed Statements of Operations.
Interest Rate Cap Agreements
The Fund has entered into interest rate cap agreements which are primarily valued on the basis of the future expected interest rates on the remaining notional principal balance. This methodology is comparable to what a prospective acquirer would use in determining the amount they would pay on the measurement date. Valuation pricing models utilized to fair value the caps consider inputs such as forward rates, anticipated interest rate volatility relating to the reference rate, as well as time value and other factors underlying cap instruments. The interest rate cap contracts are recorded in the Condensed Statement of Assets & Liabilities at the estimated fair value. Subsequent changes in fair value are recorded in the Net change in unrealized gain (loss) from investments in the Condensed Statements of Operations and the quarterly interest received on the interest rate cap contracts, if any, will be recorded in Net change in realized gain (loss) from investments in the Condensed Statements of Operations. Since inception through September 30, 2017, there has been no interest received on interest rate cap contracts.
3. SCHEDULES OF INVESTMENTS
As of September 30, 2017, all loans were made to non-affiliates as follows (unaudited):
Borrower | Percentage of Net Assets | Estimated Fair Value 9/30/2017 | Par Value 9/30/2017 | Final Maturity Date | |||||
Biotechnology | |||||||||
Orpheus Therapeutics, Inc. | $ | 129,628 | $ | 129,628 | 08/01/2020 | ||||
Phylagen, Inc. | 388,261 | 388,261 | 03/01/2020 | ||||||
Subtotal: | 0.3% | $ | 517,889 | $ | 517,889 | ||||
Computers & Storage | |||||||||
Canary Connect, Inc. | $ | 1,427,187 | $ | 1,427,187 | 12/01/2020 | ||||
Electric Objects, Inc. | 5,400 | 310,151 | * | ||||||
HyperGrid, Inc. | 1,087,272 | 1,087,272 | 12/01/2019 | ||||||
Rigetti & Co., Inc. | 3,138,505 | 3,138,505 | 01/01/2019 | ||||||
Subtotal: | 3.0% | $ | 5,658,364 | $ | 5,963,115 | ||||
Internet | |||||||||
Amino Payments, Inc. | $ | 278,225 | $ | 278,225 | 03/01/2021 | ||||
Apartment List, Inc | 1,076,729 | 1,076,729 | 11/01/2019 |
10
Borrower | Percentage of Net Assets | Estimated Fair Value 9/30/2017 | Par Value 9/30/2017 | Final Maturity Date | |||||
Better Doctor, Inc. | 1,307,949 | 1,307,949 | 12/01/2020 | ||||||
Bitfinder, Inc. | 473,674 | 473,674 | 09/01/2020 | ||||||
Blitsy, Inc. | 290,618 | 290,618 | 02/01/2019 | ||||||
Bombfell, Inc. | 945,910 | 945,910 | 04/01/2021 | ||||||
CapLinked, Inc. | 267,177 | 267,177 | 01/01/2019 | ||||||
ConnectedYard, Inc. | 468,032 | 468,032 | 06/01/2020 | ||||||
DailyFeats, Inc. | 3,421,581 | 3,421,581 | 12/01/2020 | ||||||
Darby Smart, Inc. | 1,622,073 | 1,622,073 | 02/01/2021 | ||||||
DreamCloud Holdings, LLC | 874,732 | 874,732 | 08/01/2020 | ||||||
Eventbite, Inc. | 12,978,437 | 12,978,437 | 02/01/2022 | ||||||
Handy Technologies, Inc. | 4,722,251 | 4,722,251 | 12/01/2020 | ||||||
Homelight, Inc. | 742,133 | 742,133 | 12/01/2019 | ||||||
Honk Technologies, Inc. | 2,274,336 | 2,274,336 | 05/01/2020 | ||||||
Node, Inc. | 441,675 | 441,675 | 01/01/2020 | ||||||
Placester, Inc. | 2,212,767 | 2,212,767 | 10/01/2019 | ||||||
Playstudios, Inc. | 1,183,281 | 1,183,281 | 03/01/2021 | ||||||
Radius Intelligence, Inc. | 6,940,666 | 6,940,666 | 10/01/2021 | ||||||
Relay Network, LLC | 1,909,619 | 1,909,619 | 09/01/2020 | ||||||
ShipBob, Inc. | 680,857 | 680,857 | 01/01/2020 | ||||||
Spot.IM, Ltd.** | 882,575 | 882,575 | 05/01/2020 | ||||||
Striking, Inc. | 233,184 | 466,369 | * | ||||||
Super Home, Inc. | 148,972 | 148,972 | 03/01/2019 | ||||||
Tango Card, Inc. | 1,443,966 | 1,443,966 | 11/01/2020 | ||||||
Thrive Market, Inc. | 5,482,078 | 5,482,078 | 09/01/2019 | ||||||
Tictail, Inc. | 1,104,658 | 1,104,658 | 05/01/2021 | ||||||
TouchofModern, Inc. | 4,746,606 | 4,746,606 | 05/01/2020 | ||||||
Traackr, Inc. | 434,490 | 434,490 | 04/01/2019 | ||||||
Viyet, Inc. | 363,345 | 363,345 | 06/01/2020 | ||||||
Subtotal: | 31.3% | $ | 59,952,596 | $ | 60,185,781 | ||||
Medical Devices | |||||||||
Anutra Medical, Inc. | $ | 329,204 | $ | 329,204 | 12/01/2019 | ||||
JustRight Surgical LLC | 1,534,622 | 1,534,622 | 07/01/2019 | ||||||
Keystone Heart, Inc.** | 2,751,625 | 2,751,625 | 11/01/2020 | ||||||
Renovia, Inc. | 1,900,808 | 1,900,808 | 06/01/2020 | ||||||
Subtotal: | 3.4% | $ | 6,516,259 | $ | 6,516,259 | ||||
Other Healthcare | |||||||||
4G Clinical LLC | $ | 934,740 | $ | 934,740 | 07/01/2020 | ||||
Call9, Inc. | 829,519 | 829,519 | 01/01/2021 | ||||||
Caredox, Inc. | 411,660 | 411,660 | 01/01/2019 | ||||||
Clover Health Investment Corp. | 17,890,968 | 17,890,968 | 04/01/2022 | ||||||
Driver, Inc. | 8,940,245 | 8,940,245 | 07/01/2021 | ||||||
Hello Doctor, Ltd.** | 101,894 | 101,894 | 03/01/2019 |
11
Borrower | Percentage of Net Assets | Estimated Fair Value 9/30/2017 | Par Value 9/30/2017 | Final Maturity Date | |||||
Hi.Q, Inc. | 1,926,764 | 1,926,764 | 05/01/2020 | ||||||
Lean Labs, Inc. | 170,876 | 170,876 | 04/01/2019 | ||||||
MD Revolution, Inc. | 1,061,605 | 1,061,605 | 03/01/2020 | ||||||
mPharma Data, Inc.** | 714,390 | 714,390 | 03/01/2021 | ||||||
Project Healthy Living, Inc. | 599,327 | 599,327 | 09/01/2019 | ||||||
Myolex, Inc. | 578,802 | 786,901 | 03/01/2019 | ||||||
Sparta Software Corporation | 162,672 | 162,672 | 06/01/2020 | ||||||
Trio Health Advisory Group, Inc. | 574,587 | 574,587 | 02/01/2019 | ||||||
Wellist PBC, Inc. | 293,690 | 293,690 | 12/01/2019 | ||||||
Zillion Group, Inc. | 920,154 | 920,154 | 07/01/2020 | ||||||
Subtotal: | 18.9% | $ | 36,111,893 | $ | 36,319,992 | ||||
Other Technology | |||||||||
8i Corporation | $ | 2,817,254 | $ | 2,817,254 | 12/01/2020 | ||||
Asset Avenue, Inc.** | 86,800 | 230,719 | * | ||||||
Astro, Inc. | 140,179 | 280,359 | * | ||||||
BloomLife, Inc. | 278,788 | 278,788 | 04/01/2020 | ||||||
Candy Club Holdings, Inc. | 105,279 | 105,279 | 09/01/2018 | ||||||
CommunityCo, LLC | 174,306 | 174,306 | 03/01/2019 | ||||||
Consumer Physics, Inc.** | 1,684,956 | 1,684,956 | 03/01/2019 | ||||||
Ensyn Corporation | 4,002,966 | 4,002,966 | 11/01/2019 | ||||||
Eponym, Inc. | 1,378,798 | 1,378,798 | 07/01/2021 | ||||||
ETN Media, Inc. | 685,157 | 685,157 | 07/01/2020 | ||||||
Flo Water, Inc. | 424,294 | 424,294 | 05/01/2020 | ||||||
Gap Year Global, Inc. | 136,823 | 136,823 | 10/01/2018 | ||||||
Greats Brand, Inc. | 393,358 | 393,358 | 12/01/2019 | ||||||
Heartwork, Inc. | 477,672 | 477,672 | 09/01/2020 | ||||||
Hint, Inc. | 2,229,468 | 2,229,468 | 03/01/2021 | ||||||
Hyperloop Technologies, Inc. | 6,993,436 | 6,993,436 | 06/01/2019 | ||||||
Impossible Aerospace Corporation | 464,212 | 464,212 | 08/01/2020 | ||||||
June Life, Inc. | 2,207,551 | 2,207,551 | 03/01/2020 | ||||||
LanzaTech New Zealand Ltd. | 5,834,250 | 5,834,250 | 09/01/2020 | ||||||
Neuehouse, LLC | 3,437,499 | 3,437,499 | 06/01/2019 | ||||||
North American Robotics Corporation | 458,466 | 458,466 | 08/01/2020 | ||||||
Noteleaf, Inc. | 1,437,385 | 1,437,385 | 09/01/2020 | ||||||
PDQ Enterprises LLC** | 3,373,558 | 3,373,558 | 02/01/2021 | ||||||
PLAE, Inc. | 1,430,307 | 1,430,307 | 12/01/2020 | ||||||
Planet Labs, Inc. | 11,702,156 | 11,702,156 | 11/01/2021 | ||||||
Plenty United, Inc. | 5,490,225 | 5,490,225 | 09/01/2021 | ||||||
Plethora, Inc | 1,570,924 | 1,570,924 | 03/01/2019 | ||||||
Rosco & Benedetto Co, Inc. | 290,216 | 290,216 | 09/01/2019 | ||||||
Seriforge, Inc. | 101,285 | 101,285 | 09/01/2018 | ||||||
SkyKick, Inc. | 2,372,282 | 2,372,282 | 11/01/2020 | ||||||
Terralux, Inc. | 635,232 | 761,501 | * |
12
Borrower | Percentage of Net Assets | Estimated Fair Value 9/30/2017 | Par Value 9/30/2017 | Final Maturity Date | |||||
Tri Alpha Energy, Inc. | 11,639,455 | 11,639,455 | 04/01/2021 | ||||||
Virtuix Holdings, Inc. | 707,141 | 707,141 | 07/01/2020 | ||||||
Vision Cortex, Ltd.** | 692,669 | 692,669 | 08/01/2020 | ||||||
Wine Plum, Inc. | 1,586,741 | 1,586,741 | 09/01/2019 | ||||||
Subtotal: | 40.5% | $ | 77,441,088 | $ | 77,851,456 | ||||
Security | |||||||||
Identiv, Inc.** | $ | 4,338,227 | $ | 4,338,227 | 08/01/2020 | ||||
Kryptnostic, Inc. | — | 302,293 | * | ||||||
Nok Nok Labs, Inc. | 620,894 | 620,894 | 12/01/2020 | ||||||
ThinAir Labs, Inc. | 1,172,619 | 1,172,619 | 02/01/2020 | ||||||
Subtotal: | 3.2% | $ | 6,131,740 | $ | 6,434,033 | ||||
Semiconductors & Equipment | |||||||||
ETA Compute, Inc. | $ | 446,590 | $ | 446,590 | 10/01/2019 | ||||
Subtotal: | 0.2% | $ | 446,590 | $ | 446,590 | ||||
Software | |||||||||
Addepar, Inc. | $ | 1,966,086 | $ | 1,966,086 | 06/01/2018 | ||||
Alpha UX, Inc. | 462,903 | 462,903 | 08/01/2020 | ||||||
Apptimize, Inc. | 517,282 | 517,282 | 03/01/2019 | ||||||
Aptible, Inc. | 237,582 | 237,582 | 02/01/2021 | ||||||
Bloomboard, Inc. | 1,520,442 | 2,020,527 | * | ||||||
BlueCart, Inc. | 624,514 | 624,514 | 01/01/2020 | ||||||
DealPath, Inc. | 1,546,418 | 1,546,418 | 05/01/2021 | ||||||
DemystData Limited | 1,392,596 | 1,392,596 | 07/01/2020 | ||||||
Drift Marketplace, Inc. | 601,890 | 601,890 | 03/01/2020 | ||||||
Estify, Inc. | 465,801 | 465,801 | 05/01/2020 | ||||||
Gearbox Software, LLC | 2,677,469 | 2,677,469 | 09/01/2020 | ||||||
GoFormz, Inc. | 1,157,255 | 1,157,255 | 11/01/2020 | ||||||
HealthPrize Technologies, LLC | 215,638 | 215,638 | 12/01/2019 | ||||||
IntelinAir, Inc. | 167,903 | 167,903 | 06/01/2019 | ||||||
Interset Software, Inc.** | 1,712,757 | 1,712,757 | 10/01/2020 | ||||||
Invoice2Go, Inc. | 4,276,592 | 4,276,592 | 04/01/2021 | ||||||
JethroData, Inc.** | 919,188 | 919,188 | 10/01/2019 | ||||||
Libre Wireless Technologies, Inc. | 438,259 | 438,259 | 01/01/2020 | ||||||
Meta Company | 4,748,419 | 4,748,419 | 06/01/2021 | ||||||
Mine.io** | 457,177 | 457,177 | 07/01/2020 | ||||||
Mintigo, Inc.** | 1,095,910 | 1,095,910 | 07/01/2020 | ||||||
PowerInbox, Inc. | 359,942 | 359,942 | 06/01/2020 | ||||||
Swrve, Inc. | 1,871,743 | 1,871,743 | 05/01/2020 | ||||||
The/Studio Technologies, Inc. | 673,741 | 673,741 | 06/01/2020 | ||||||
Unmetric, Inc. | 335,856 | 335,856 | 02/01/2020 | ||||||
VenueNext, Inc. | 1,370,017 | 1,370,017 | 05/01/2020 |
13
Borrower | Percentage of Net Assets | Estimated Fair Value 9/30/2017 | Par Value 9/30/2017 | Final Maturity Date | |||||
Vuemix, Inc. | 231,716 | 231,716 | 11/01/2020 | ||||||
Wayfare Interactive, Inc. | 663,672 | 663,672 | 06/01/2021 | ||||||
Workspot, Inc. | 1,086,963 | 1,086,963 | 06/01/2020 | ||||||
Xeeva | 2,338,574 | 2,338,574 | 03/01/2020 | ||||||
ZeroTurnaround USA, Inc.** | 1,855,564 | 1,855,564 | 06/01/2021 | ||||||
Zodiac, Inc. | 552,030 | 552,030 | 07/01/2019 | ||||||
Subtotal: | 20.1% | $ | 38,541,899 | $ | 39,041,984 | ||||
Technology Services | |||||||||
AirHelp, Inc. | $ | 1,785,018 | $ | 1,785,018 | 07/01/2020 | ||||
Akademos, Inc.*** | 828,338 | 828,338 | 08/01/2020 | ||||||
Ascend Consumer Finance, Inc.** | 48,000 | 360,820 | * | ||||||
Blazent, Inc. | 2,959,381 | 2,959,381 | 08/01/2020 | ||||||
Blue Technologies Limited** | 1,567,522 | 1,567,522 | 04/01/2020 | ||||||
Callisto Media, Inc. | 5,333,140 | 5,333,140 | 03/01/2021 | ||||||
Dolly, Inc. | 829,579 | 829,579 | 06/01/2020 | ||||||
FSA Store, Inc. | 2,313,624 | 2,313,624 | 12/01/2020 | ||||||
Iris.tv, Inc. | 854,111 | 854,111 | 02/01/2021 | ||||||
Maxi Mobility, Inc. | 19,063,535 | 19,063,535 | 01/01/2021 | ||||||
ParkJockey Global, Inc. | 704,639 | 704,639 | 06/01/2019 | ||||||
Particle Industries, Inc. | 827,914 | 827,914 | 11/01/2019 | ||||||
PayJoy, Inc.** | 352,520 | 352,520 | 08/01/2019 | ||||||
Sixup PBC, Inc.** | 435,934 | 435,934 | 06/01/2019 | ||||||
TrueFacet, Inc. | 1,200,895 | 1,200,895 | 06/01/2021 | ||||||
Zeel Networks, Inc. | 1,925,286 | 1,925,286 | 08/01/2020 | ||||||
Subtotal: | 21.4% | $ | 41,029,436 | $ | 41,342,256 | ||||
Wireless | |||||||||
Bluesmart, Inc. | $ | 1,384,274 | $ | 1,384,274 | 09/01/2019 | ||||
InVenture Capital Corporation** | 1,054,824 | 1,054,824 | 09/01/2019 | ||||||
Juvo Mobile, Inc. ** | 1,321,001 | 1,321,001 | 02/01/2020 | ||||||
Nextivity, Inc. | 5,442,226 | 5,442,226 | 06/01/2021 | ||||||
Parallel Wireless, Inc. | 4,802,620 | 4,802,620 | 04/01/2020 | ||||||
Subtotal: | 7.3% | $ | 14,004,945 | $ | 14,004,945 | ||||
Total Loans (Cost of $288,624,300) | 149.6% | $ | 286,352,699 | $ | 288,624,300 | ||||
Interest Rate Caps (Cost of $80,529) | 0.0% | $ | 45,901 | $ | 80,529 | ||||
Total Investments (Cost of $288,704,829) | 149.6% | $ | 286,398,600 | $ | 288,704,829 |
* As of September 30, 2017, loans with a cost basis of $4.7 million and a fair value $2.7 million of have been classified as non-accrual.
** Indicates assets that the Fund deems “non-qualifying assets” under Section 55(a) of the 1940 Act. Qualifying assets
14
must represent at least 70% of the Fund’s total assets at the time of acquisition of any additional non-qualifying assets. As of September 30, 2017, 8.4% of the Fund’s assets represented non-qualifying assets. As part of this calculation, the numerator consists of all eligible portfolio companies as defined in Section 2(a)(46); and the denominator consists of total assets less the assets described in Section 55(a)(7).
***Indicates assets that are not senior loans.
As of December 31, 2016, all loans were made to non-affiliates as follows:
Borrowers | Percentage of Net Assets | Estimated Fair Value 12/31/2016 | Par Value 12/31/2016 | Final Maturity Date | |||||
Biotechnology | |||||||||
Phylagen, Inc. | $ | 458,705 | $ | 458,705 | 03/01/2020 | ||||
Subtotal: | 0.6% | 458,705 | 458,705 | ||||||
Computers & Storage | |||||||||
Canary Connect, Inc. | $ | 1,408,716 | $ | 1,408,716 | 12/01/2020 | ||||
Electric Objects, Inc. | 346,149 | 346,149 | 09/01/2019 | ||||||
HyperGrid, Inc. | 1,170,799 | 1,170,799 | 12/01/2019 | ||||||
Rigetti & Co., Inc. | 3,456,371 | 3,456,371 | 01/01/2020 | ||||||
Subtotal: | 7.9% | 6,382,035 | 6,382,035 | ||||||
Internet | |||||||||
Apartment List, Inc | $ | 1,376,349 | $ | 1,376,349 | 11/01/2019 | ||||
Apsalar, Inc. | 945,893 | 945,893 | 11/01/2019 | ||||||
Blitsy, Inc. | 422,582 | 422,582 | 02/01/2019 | ||||||
CapLinked, Inc. | 397,321 | 397,321 | 01/01/2019 | ||||||
Finrise, Inc. | 222,320 | 222,320 | 09/01/2019 | ||||||
HEXAGRAM49, Inc. | 5,000 | 423,906 | * | ||||||
Homelight, Inc. | 943,900 | 943,900 | 12/01/2019 | ||||||
Honk Technologies, Inc. | 1,396,791 | 1,396,791 | 12/01/2019 | ||||||
PerformLine, Inc. | 857,624 | 857,624 | 06/01/2019 | ||||||
Placester, Inc. | 2,542,991 | 2,542,991 | 10/01/2019 | ||||||
Playstudios, Inc. | 1,166,728 | 1,166,728 | 03/01/2021 | ||||||
ShipBob, Inc. | 468,983 | 468,983 | 01/01/2020 | ||||||
Spot.IM, Ltd. ** | 439,416 | 439,416 | 12/01/2019 | ||||||
Striking, Inc. | 472,523 | 472,523 | 06/01/2019 | ||||||
Super Home, Inc. | 209,758 | 209,758 | 03/01/2019 | ||||||
Thrive Market, Inc. | 7,156,594 | 7,156,594 | 09/01/2019 | ||||||
Tictail, Inc. | 356,102 | 356,102 | 07/01/2020 | ||||||
TouchofModern, Inc. | 5,724,450 | 5,724,450 | 05/01/2020 | ||||||
Traackr, Inc. | 628,107 | 628,107 | 04/01/2019 | ||||||
Viyet, Inc. | 189,322 | 189,322 | 01/01/2019 | ||||||
Subtotal: | 32.0% | $ | 25,922,754 | $ | 26,341,660 | ||||
15
Borrowers | Percentage of Net Assets | Estimated Fair Value 12/31/2016 | Par Value 12/31/2016 | Final Maturity Date | |||||
Medical Devices | |||||||||
Anutra Medical, Inc. | $ | 235,713 | $ | 235,713 | 12/01/2019 | ||||
JustRight Surgical LLC | 2,117,580 | 2,117,580 | 07/01/2019 | ||||||
Subtotal: | 2.9% | $ | 2,353,293 | $ | 2,353,293 | ||||
Other Healthcare | |||||||||
Caredox, Inc. | $ | 610,141 | $ | 610,141 | 01/01/2019 | ||||
Cogito Corporation | 708,757 | 708,757 | 09/01/2019 | ||||||
Hello Doctor, Ltd.** | 141,167 | 141,167 | 03/01/2019 | ||||||
Hi.Q, Inc. | 1,908,659 | 1,908,659 | 05/01/2020 | ||||||
Lean Labs, Inc. | 214,224.00 | 214,224.00 | 12/01/2018 | ||||||
MD Revolution, Inc. | 1,029,568 | 1,029,568 | 03/01/2020 | ||||||
Project Healthy Living, Inc. | 777,742 | 777,742 | 12/01/2018 | ||||||
Skulpt, Inc. | 872,416 | 872,416 | 03/01/2019 | ||||||
Trio Health Advisory Group, Inc. | 828,757 | 828,757 | 02/01/2019 | ||||||
Wellist PBC, Inc. | 354,443 | 354,443 | 12/01/2019 | ||||||
Subtotal: | 9.2% | $ | 7,445,874 | $ | 7,445,874 | ||||
Other Technology | |||||||||
AltspaceVR, Inc. | $ | 1,413,131 | $ | 1,413,131 | 12/01/2019 | ||||
Asset Avenue, Inc.** | 375,000 | 663,823 | * | ||||||
Astro, Inc. | 322,296 | 322,296 | 09/01/2019 | ||||||
Automatic Labs, Inc. | 2,358,518 | 2,358,518 | 12/01/2018 | ||||||
Candy Club Holdings, Inc. | 173,491 | 173,491 | 09/01/2018 | ||||||
CommunityCo, LLC | 241,801 | 241,801 | 03/01/2019 | ||||||
Daylight Solutions, Inc. | 789,228 | 789,228 | 12/01/2018 | ||||||
Ensyn Corporation | 5,248,499 | 5,248,499 | 11/01/2019 | ||||||
Eponym, Inc. | 1,219,791 | 1,219,791 | 11/01/2019 | ||||||
Flo Water, Inc. | 482,791 | 482,791 | 05/01/2020 | ||||||
Gap Year Global, Inc. | 183,583 | 183,583 | 10/01/2018 | ||||||
Greats Brand, Inc. | 459,163 | 459,163 | 12/01/2019 | ||||||
Hyperloop Technologies, Inc. | 9,368,246 | 9,368,246 | 06/01/2019 | ||||||
June Life, Inc. | 1,161,094 | 1,161,094 | 03/01/2020 | ||||||
Knockaway, Inc. | 233,741 | 233,741 | 09/01/2019 | ||||||
Neuehouse, LLC | 4,615,498 | 4,615,498 | 06/01/2019 | ||||||
One Financial Holdings Group, Inc. | 662,491 | 662,491 | 04/01/2019 | ||||||
Owlet Baby Care, Inc. | 855,802 | 855,802 | 03/01/2019 | ||||||
Plethora, Inc | 2,195,301 | 2,195,301 | 03/01/2019 | ||||||
Rosco & Benedetto Co, Inc. | 345,735 | 345,735 | 09/01/2019 | ||||||
See Jane Farm, Inc. | 1,281,788 | 1,281,788 | 01/01/2021 | ||||||
Seriforge, Inc. | 163,971 | 163,971 | 09/01/2018 | ||||||
Skully, Inc. | 237,075 | 2,363,124 | * | ||||||
Street League, Inc. | 348,510 | 348,510 | 07/01/2020 | ||||||
16
Borrowers | Percentage of Net Assets | Estimated Fair Value 12/31/2016 | Par Value 12/31/2016 | Final Maturity Date | |||||
Terralux, Inc. | 1,238,167 | 1,238,167 | 03/01/2019 | ||||||
Wine Plum, Inc. | 1,428,346 | 1,428,346 | 09/01/2019 | ||||||
Subtotal: | 46.1% | $ | 37,403,057 | $ | 39,817,929 | ||||
Security | |||||||||
Bottlenose, Inc. | $ | 700,000 | $ | 1,182,135 | * | ||||
Kryptnostic, Inc. | 477,043 | 477,043 | 06/01/2019 | ||||||
ThinAir Labs, Inc. | 1,193,325 | 1,193,325 | 02/01/2020 | ||||||
Subtotal: | 2.9% | $ | 2,370,368 | $ | 2,852,503 | ||||
Semiconductors & Equipment | |||||||||
ETA Compute, Inc. | $ | 235,020 | $ | 235,020 | 10/01/2019 | ||||
Subtotal: | 0.3% | $ | 235,020 | $ | 235,020 | ||||
Software | |||||||||
Addepar, Inc. | $ | 3,736,495 | $ | 3,736,495 | 06/01/2018 | ||||
Apptimize, Inc. | 788,145 | 788,145 | 03/01/2019 | ||||||
Bloomboard, Inc. | 1,933,735 | 1,933,735 | 08/01/2019 | ||||||
BlueCart, Inc. | 467,675 | 467,675 | 01/01/2020 | ||||||
Bounce Exchange, Inc. | 1,414,450 | 1,414,450 | 05/01/2020 | ||||||
Drift Marketplace, Inc. | 169,143 | 169,143 | 03/01/2020 | ||||||
HealthPrize Technologies, LLC | 231,169 | 231,169 | 12/01/2019 | ||||||
IntelinAir, Inc. | 224,388 | 224,388 | 06/01/2019 | ||||||
Interset Software, Inc. ** | 1,192,711 | 1,192,711 | 10/01/2019 | ||||||
Invoice2Go, Inc. | 866,019 | 866,019 | 06/01/2020 | ||||||
JethroData, Inc. ** | 1,063,724 | 1,063,724 | 10/01/2019 | ||||||
Mintigo, Inc. ** | 575,091 | 575,091 | 04/01/2020 | ||||||
Swift Pursuits, Inc. | 444,591 | 444,591 | 04/01/2020 | ||||||
Swrve, Inc. | 1,896,971 | 1,896,971 | 05/01/2020 | ||||||
Toast, Inc.*** | 409,136 | 409,136 | 01/01/2019 | ||||||
Unmetric, Inc. | 334,047 | 334,047 | 02/01/2020 | ||||||
Workspot, Inc. | 604,544 | 604,544 | 02/01/2019 | ||||||
Xeeva | 2,391,498 | 2,391,498 | 06/01/2019 | ||||||
Zodiac, Inc. | 720,349 | 720,349 | 07/01/2019 | ||||||
Subtotal: | 24.0% | $ | 19,463,881 | $ | 19,463,881 | ||||
Technology Services | |||||||||
Ascend Consumer Finance, Inc. ** | $ | 437,702 | $ | 437,702 | 03/01/2019 | ||||
Blazent, Inc. | 1,915,129 | 1,915,129 | 01/01/2020 | ||||||
Blue Technologies Limited ** | 1,164,586 | 1,164,586 | 12/01/2019 | ||||||
Callisto Media, Inc. | 2,385,198 | 2,385,198 | 06/01/2020 | ||||||
Iris.tv, Inc. | 221,259 | 221,259 | 04/01/2019 | ||||||
ParkJockey Global, Inc. | 954,941 | 954,941 | 06/01/2019 | ||||||
Particle Industries, Inc. | 935,640 | 935,640 | 11/01/2019 |
17
Borrowers | Percentage of Net Assets | Estimated Fair Value 12/31/2016 | Par Value 12/31/2016 | Final Maturity Date | |||||
PayJoy, Inc.** | 463,591 | 463,591 | 08/01/2019 | ||||||
Sixup PBC, Inc. ** | 588,324 | 588,324 | 06/01/2019 | ||||||
TrueFacet, Inc. | 704,807 | 704,807 | 08/01/2020 | ||||||
Zeel Networks, Inc. | 934,554 | 934,554 | 08/01/2020 | ||||||
Subtotal: | 13.2% | $ | 10,705,731 | $ | 10,705,731 | ||||
Wireless | |||||||||
Bluesmart, Inc. | $ | 1,769,431 | $ | 1,769,431 | 09/01/2019 | ||||
InVenture Capital Corporation ** | 1,373,749 | 1,373,749 | 09/01/2019 | ||||||
Juvo Mobile, Inc. ** | 948,131 | 948,131 | 01/01/2020 | ||||||
Nextivity, Inc. | 5,425,716 | 5,425,716 | 06/01/2021 | ||||||
Parallel Wireless, Inc. | 3,292,912 | 3,292,912 | 04/01/2020 | ||||||
Subtotal: | 15.8% | $ | 12,809,939 | $ | 12,809,939 | ||||
Total Loans (Cost of $128,866,570) | 154.9% | $ | 125,550,657 | $ | 128,866,570 | ||||
Interest Rate Caps (Cost of $57,806) | 0.1% | $ | 117,849 | $ | 57,806 | ||||
Total Investments (Cost $128,924,376) | 155.0% | $ | 125,668,506 | $ | 128,924,376 |
* As of December 31, 2016, loans with a cost basis of $4.6 million and fair value of $1.3 million were classified as non-accrual. These loans have been accelerated from their original maturity and are due in their entirety. During the period for which these loans have been on non-accrual status, no interest income has been recognized.
** Indicates assets that the Fund deems “non-qualifying assets” under Section 55(a) of the 1940 Act. Qualifying assets must represent at least 70% of the Fund’s total assets at the time of acquisition of any additional non-qualifying assets. As of December 31, 2016, 6.5% of the Fund’s assets represented non-qualifying assets. As part of this calculation, the numerator consists of all eligible portfolio companies as defined in Section 2(a)(46); and the denominator consists of total assets less the assets described in Section 55(a)(7).
***Indicates assets that are not senior loans.
4. FAIR VALUE DISCLOSURES
The Fund provides asset-based financing primarily to start-up and emerging growth venture-capital-backed companies which are generally made to borrowers pursuant to commitments whereby the Fund agrees to finance assets and provide working capital or growth up to a specified amount for the term of the commitment, upon the terms and subject to the conditions specified by such commitment. Even though these loans are generally secured by the assets of the borrowers, the Fund in most cases is subject to the credit risk of such companies. As of September 30, 2017, the Fund’s investments in loans were primarily to companies based within the United States and were diversified among borrowers in the industry segments shown below. The percentage of net assets that each industry group represents is shown with the industry totals below (the sum of the percentages does not equal 100 percent because the percentages are based on net assets as opposed to total loans). All loans are senior to unsecured creditors and other secured creditors, except as indicated in the Schedule above. Loans to Akademos, Inc. and Toast, Inc. are subordinated to other secured creditors.
Loan balances in the tables below are summarized by borrower. Typically a borrower’s balance will be composed of several loans drawn under a commitment made by the Fund with the interest rate on each loan fixed at the time each loan is funded. Each loan drawn under a commitment may have a different maturity date and amount. For the three and
18
nine months ended September 30, 2017 , the weighted-average interest rate on performing loans was 15.25% and 15.69% respectively. For the three and nine months ended September 30, 2016, the weighted-average interest rate on performing loan was 15.17% and 15.62%, respectively. This rate is inclusive of both cash and non-cash interest income. For the three and nine months ended September 30, 2017, the cash portion of the interest income was 12.35% and 12.58% respectively. For the three and nine months ended September 30, 2016, the cash portion of the interest income was 11.73% and 11.98%, respectively. Interest is calculated using the effective interest method, and rates earned by the Fund will fluctuate based on many factors including early payoffs, volatility of values ascribed to warrants and new loans funded during the period.
The risk profile of a loan changes when events occur that impact the credit analysis of the borrower and loan as described in our loan accounting policy. Such changes result in the fair value adjustments made to the individual loans,which in accordance with GAAP, would be based on the price that would be received to sell an asset or paid to settle a liability in an orderly transaction between market participants at the measurement date. Where the risk profile is consistent with the original underwriting, which is primarily the case for this loan portfolio, the par value of the loan will approximate fair value.
All loans as of September 30, 2017 and 2016 were pledged as collateral for the debt facility, and the Fund’s borrowings are subsequently collateralized by all assets of the Fund. As of September 30, 2017 and December 31, 2016, the Fund has unexpired commitments to borrowers of $75.1 million and $53.4 million, respectively.
Valuation Hierarchy
Under the FASB Accounting Standards Codification (“ASC”) 820-10 “Fair Value Measurements”, the Fund categorizes its fair value measurements in a three-level hierarchy that prioritizes the inputs used by the Fund’’s valuation techniques. A level is assigned to each fair value measurement based on the lowest level input that is significant to the fair value measurement in its entirety. The three levels of the fair value hierarchy are defined as follows:
Level 1 | Unadjusted quoted prices for identical assets or liabilities in active markets that are accessible at the measurement date. | |
Level 2 | Prices or valuations based on observable inputs other than quoted prices in active markets for identical assets and liabilities. | |
Level 3 | Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable. |
Transfers of investments between levels of the fair value hierarchy are recorded on the actual date of the event or change in circumstances that caused the transfer. There were no transfers in and out of Level 1, 2, and 3 during the period ended September 30, 2017 and September 30, 2016.
The Fund’s cash equivalents were valued at the traded net asset value of the money market mutual fund, and therefore, these measurements are classified as Level 1. The Fund’s investments in the interest rate cap are based on quotes from the market makers that derive fair values from market data, and therefore, they are classified as Level 2 items.
The Fund’s loan transactions are individually negotiated and unique, and because there is no market in which these assets trade, the inputs for these assets, which are valued using estimated exit values, are classified as Level 3.
The following tables provide quantitative information about the Fund’s Level 3 fair value measurements of its investments as of September 30, 2017 and December 31, 2016. In addition to the techniques and inputs noted in the tables below, the Fund may also use other valuation techniques and methodologies when determining its fair value measurements.
19
Investment Type - Level 3 | ||||||||||
Debt Investments | Fair Value at 09/30/17 | Valuation Techniques / Methodologies | Unobservable Input | Weighted Average / Amount or Range | ||||||
Biotechnology | $ | 517,889 | Hypothetical market analysis | Hypothetical market coupon rate | 16% | |||||
Computers & Storage | $ | 5,658,364 | Hypothetical market analysis | Hypothetical market coupon rate | 14% | |||||
Liquidation | Investment Collateral | $5,400 | ||||||||
Internet | $ | 59,952,596 | Hypothetical market analysis | Hypothetical market coupon rate | 15% | |||||
Liquidation | Investment Collateral | $233,184 | ||||||||
Medical Device | $ | 6,516,259 | Hypothetical market analysis | Hypothetical market coupon rate | 16% | |||||
Other Healthcare | $ | 36,111,893 | Hypothetical market analysis | Hypothetical market coupon rate | 16% | |||||
Other Technology | $ | 77,441,088 | Hypothetical market analysis | Hypothetical market coupon rate | 15% | |||||
Liquidation | Investment Collateral | $86,800 - $635,232 | ||||||||
Security | $ | 6,131,740 | Hypothetical market analysis | Hypothetical market coupon rate | 20% | |||||
Liquidation | Investment Collateral | $0 | ||||||||
Semiconductors & Equipment | $ | 446,590 | Hypothetical market analysis | Hypothetical market coupon rate | 13% | |||||
Software | $ | 38,541,899 | Hypothetical market analysis | Hypothetical market coupon rate | 15% | |||||
Liquidation | Investment Collateral | $1,520,442 | ||||||||
Technology Services | $ | 41,029,436 | Hypothetical market analysis | Hypothetical market coupon rate | 13% | |||||
Liquidation | Investment Collateral | $48,000 | ||||||||
Wireless | $ | 14,004,945 | Hypothetical market analysis | Hypothetical market coupon rate | 13% | |||||
$ | 286,352,699 |
20
Investment Type - Level 3 | ||||||||||
Debt Investments | Fair Value at 12/31/2016 | Valuation Techniques / Methodologies | Unobservable Input | Weighted Average / Amount or Range | ||||||
Computers & Storage | $ | 6,382,035 | Hypothetical market analysis | Hypothetical market coupon rate | 14% | |||||
Internet | $ | 25,922,754 | Hypothetical market analysis | Hypothetical market coupon rate | 15% | |||||
Liquidation | Investment Collateral | $5,000 | ||||||||
Medical Devices | $ | 2,353,293 | Hypothetical market analysis | Hypothetical market coupon rate | 17% | |||||
Other Healthcare | $ | 7,445,874 | Hypothetical market analysis | Hypothetical market coupon rate | 15% | |||||
Other Technology | $ | 37,403,057 | Hypothetical market analysis | Hypothetical market coupon rate | 16% | |||||
Liquidation | Investment Collateral | $237,075 - $375,000 | ||||||||
Security | $ | 2,370,368 | Hypothetical market analysis | Hypothetical market coupon rate | 16% | |||||
Liquidation | Investment Collateral | $700,000 | ||||||||
Software | $ | 19,463,881 | Hypothetical market analysis | Hypothetical market coupon rate | 15% | |||||
Technology Services | $ | 10,705,731 | Hypothetical market analysis | Hypothetical market coupon rate | 14% | |||||
Wireless | $ | 12,809,939 | Hypothetical market analysis | Hypothetical market coupon rate | 13% | |||||
Other* | $ | 693,725 | Hypothetical market analysis | Hypothetical market coupon rate | 15% | |||||
$ | 125,550,657 |
* Other loans, as of December 31, 2016, were comprised of companies in the Biotechnology and Semiconductors & Equipment industries.
21
The following table presents the balances of assets as of September 30, 2017 and December 31, 2016 measured at fair value on a recurring basis:
As of September 30, 2017 | Level 1 | Level 2 | Level 3 | Total | |||||||||||
ASSETS: | |||||||||||||||
Loans* | $ | — | $ | — | $ | 286,352,699 | $ | 286,352,699 | |||||||
Interest rate cap | — | 45,901 | — | 45,901 | |||||||||||
Cash equivalents | 15,353,728 | — | — | 15,353,728 | |||||||||||
Total | $ | 15,353,728 | $ | 45,901 | $ | 286,352,699 | $ | 301,752,328 |
As of December 31, 2016 | Level 1 | Level 2 | Level 3 | Total | |||||||||||
ASSETS: | |||||||||||||||
Loans* | $ | — | $ | — | $ | 125,550,657 | $ | 125,550,657 | |||||||
Interest rate cap | — | 117,849 | — | 117,849 | |||||||||||
Cash equivalents | 9,821,733 | — | — | 9,821,733 | |||||||||||
Total | $ | 9,821,733 | $ | 117,849 | $ | 125,550,657 | $ | 135,490,239 |
*For a detailed listing of borrowers comprising this amount, please refer to Note 3, Schedules of Investments.
The following table provides a summary of changes in Level 3 assets measured at fair value on a recurring basis:
For the Three Months Ended September 30, 2017 | |||||||||||||||
Loans | Stock | Warrants | Convertible Note | ||||||||||||
Beginning balance | $ | 234,057,143 | $ | — | $ | — | $ | — | |||||||
Acquisitions and originations | 69,665,000 | 38,461 | 3,387,400 | — | |||||||||||
Principal reductions | (16,800,917 | ) | — | — | — | ||||||||||
Distributed to shareholder | — | (38,461 | ) | (3,387,400 | ) | — | |||||||||
Net change in unrealized gain from investments | (36,068 | ) | — | — | — | ||||||||||
Net realized loss from investments | (532,459 | ) | — | — | — | ||||||||||
Ending balance | $ | 286,352,699 | $ | — | $ | — | $ | — | |||||||
Net change in unrealized loss on investments relating to investments still held at September 30, 2017 | $ | (568,608 | ) |
For the nine months ended September 30, 2017 | |||||||||||||||
Loans | Stock | Warrants | Convertible Note | ||||||||||||
Beginning balance | $ | 125,550,657 | $ | — | $ | — | $ | — | |||||||
Acquisitions and originations | 209,767,500 | 38,935 | 14,516,109 | 17,507 | |||||||||||
Principal reductions | (46,238,291 | ) | — | — | — | ||||||||||
Distributed to shareholder | — | (38,935 | ) | (14,516,109 | ) | (17,507 | ) | ||||||||
Net change in unrealized gain from investments | 1,044,313 | — | — | — | |||||||||||
Net realized loss from investments | (3,771,480 | ) | — | — | — | ||||||||||
Ending balance | $ | 286,352,699 | $ | — | $ | — | $ | — | |||||||
Net change in unrealized loss on investments relating to investments still held at September 30, 2017 | $ | (1,982,777 | ) |
22
For the Three Months Ended September 30, 2016 | |||||||||||
Loans | Warrants | Convertible Note | |||||||||
Beginning balance | $ | 80,466,310 | $ | — | $ | — | |||||
Acquisitions and originations | 19,700,000 | 1,244,322 | 17,767 | ||||||||
Principal reductions | (2,765,792 | ) | — | — | |||||||
Distributed to shareholder | — | (1,244,322 | ) | (17,767 | ) | ||||||
Net change in unrealized loss from investments | (2,088,593 | ) | — | ||||||||
Ending balance | $ | 95,311,925 | $ | — | $ | — | |||||
Net change in unrealized loss on investments relating to investments still held at September 30, 2016 | $ | (2,088,593 | ) |
For the Nine Months Ended September 30, 2016 | |||||||||||
Loans | Warrants | Convertible Note | |||||||||
Beginning balance | $ | 26,231,626 | $ | — | $ | — | |||||
Acquisitions and originations | 77,777,273 | 5,146,571 | 17,767 | ||||||||
Principal reductions | (6,608,381 | ) | — | — | |||||||
Distributed to shareholder | — | (5,146,571 | ) | (17,767 | ) | ||||||
Net change in unrealized loss from investments | (2,088,593 | ) | — | ||||||||
Ending balance | $ | 95,311,925 | $ | — | $ | — | |||||
Net change in unrealized loss on investments relating to investments still held at September 30, 2016 | $ | (2,088,593 | ) |
5. | EARNINGS PER SHARE |
Basic earnings per share are computed by dividing net increase (decrease) in net assets resulting from operations by the weighted average common shares outstanding. Diluted earnings per share are computed by dividing net increase (decrease) in net assets resulting from operations by the weighted average common shares outstanding, including the dilutive effects of potential common shares (e.g., stock options). The Fund held no instruments that would be potential common shares; thus, reported basic and diluted earnings per share are the same.
6. | CAPITAL STOCK |
As of September 30, 2017 and December 31, 2016, there were 10,000,000 shares of $0.001 par value common stock authorized, and 100,000 shares issued and outstanding. Total committed capital of the Company, as of September 30, 2017 and December 31, 2016 was $423.6 million, respectively. Total contributed capital to the Company through September 30, 2017 and December 31, 2016 was $249.9 million and $116.5 million, of which $213.1 million and $97.9 million was contributed to the Fund, respectively.
23
The chart below shows the distributions of the Fund for the nine months ended September 30, 2017 and 2016.
For the Nine Months Ended September 30, 2017 | For the Nine Months Ended September 30, 2016 | ||||||
Cash distributions | $ | — | $ | — | |||
Distributions of equity securities | $ | 14,572,551 | $ | 5,164,338 | |||
Total distributions to shareholder | $ | 14,572,551 | $ | 5,164,338 |
Final classification of the distributions as either a return of capital or a distribution of income is an annual determination made at the end of each year dependent upon the Fund’s current year and cumulative earnings and profits.
7. DEBT FACILITY
On April 5, 2016, the Fund established a secured revolving loan facility in an initial amount up to $150,000,000, (the “Loan Agreement”) led by Wells Fargo, N.A. and MUFG Union Bank, N.A. On September 11, 2017, the Loan Agreement was amended (the “Amended Loan Agreement”). On September 11, 2017, the borrowing availability thereunder increased the size of the facility to $280,000,000. An additional $75,000,000 is potentially available to the Fund, subject to further negotiation and credit approval, through an accordion provision contained in the Amended Loan Agreement. All of the assets of the Fund collateralize borrowings by the Fund. Loans under the facility may be, at the option of the Fund, a Reference Rate Loan, a LIBOR Rate Loan, or a LIBOR Market Index Rate Loan. A Reference Rate Loan is defined as a loan bearing interest at the highest of: (a) the Federal Funds Rate for such day plus one half of one percent (0.50%), (b) the Prime Rate, and (c) LIBOR plus one percent (1%) (“Reference Rate”"). A LIBOR Rate Loan is defined as a Loan bearing interest at the prevailing LIBOR rate for a period equal to the applicable LIBOR Loan Period which appears on the Reuters Screen LIBOR01 Page (or any applicable successor page) at approximately 11:00 a.m. (London time) two (2) Business Days prior to the first day of the applicable LIBOR Loan Period (rounded upward, if necessary, to the nearest 1/100th of 1%) (“LIBOR Rate”). A LIBOR Market Index Rate Loan is defined as a Loan bearing interest, for any day, a variable rate of interest equal to the one-month LIBOR Market Index Rate based on a minimum deposit of at least $5.0 million for a period equal to one month which appears on the Reuters Screen LIBOR01 Page (or any applicable successor page) at approximately 11:00 a.m. (London time) on such date of determination, or if not a business day, then the immediate preceding business day (rounded upward, if necessary to the nearest 1/100th of 1%). As of September 30, 2017, the Fund’s outstanding borrowings were entirely based on the LIBOR Rate. The facility terminates on September 11, 2020, but can be accelerated in the event of default, such as failure by the Fund to make timely interest or principal payments.
Borrowings under the facility are collateralized by receivables under loans to portfolio companies advanced by the Fund with assignment of such receivables to the financial institution, plus all other assets of the Fund. Under the Amended Loan Agreement, interest is charged to the Fund based on its borrowings at, the election of the Fund, an annual rate equal to either (i) LIBOR plus 2.75%, (ii) the Reference Rate plus 1.75%, or (iii) the LIBOR Market Index Rate plus 2.75%. The Fund also pays an annual commitment fee under the Amended Loan Agreement. When the Fund is using 50% or more of the maximum amount available under the Amended Loan Agreement, the applicable commitment fee is 0.25% of the unused portion of the loan facility; otherwise, the applicable commitment fee is 0.50% of the unused portion. The Fund pays the unused line fee quarterly. The Fund will pay interest on its borrowings upon each maturity date. As of September 30, 2017 and December 31, 2016, $113.0 million and $53.0 million was outstanding under the facility, respectively.
As of September 30, 2017, the LIBOR Rate is as follows:
1 Month LIBOR | 1.2322% |
3 Month LIBOR | 1.3339% |
24
Bank fees and other costs of $2.1 million were incurred in connection with the facility. The bank fees and other costs incurred have been capitalized and are amortized to interest expense on a straight-line basis over the expected life of the facility. As of September 30, 2017, the remaining unamortized fees and costs of $1.6 million are being amortized over the expected life of the facility, which is expected to terminate on September 11, 2020.
The facility is revolving and as such does not have a specified repayment schedule, although advances are secured by the assets of the Fund and thus repayments will be required as assets decline. The facility contains various covenants including financial covenants related to: (i) minimum debt service coverage ratio, (ii) interest coverage ratio, (iii) maximum loan loss reserves, (iv) unfunded commitment ratio, (v) Maximum Loan Loss Test and (vi) Covenant Deferral Condition. There are also various restrictive covenants, including limitations on (i) the incurrence of liens, (ii) consolidations, mergers and asset sales, and (iii) capital expenditures. As of September 30, 2017, Management believes that the Fund was in compliance with these covenants.
The following is the summary of the outstanding facility draws as of September 30, 2017:
Roll-over/Draw Date | Amount | Maturity Date | All-In Interest Rate** | ||
August 2, 2017 | $ | 5,000,000 | 10/31/2017* | 4.07% | |
August 17, 2017 | $ | 93,000,000 | 10/31/2017* | 4.07% | |
September 28, 2017 | $ | 15,000,000 | 11/27/2017 | 4.03% | |
TOTAL OUTSTANDING | $ | 113,000,000 |
* On October 31, 2017, Management rolled over the outstanding amount to a new three month LIBOR loan, maturing on January 29, 2018 with an All-In Interest Rate of 4.13%.
** Inclusive of 2.75% applicable LIBOR margin plus LIBOR rate.
8. INTEREST RATE CAP AGREEMENT
The Fund had entered into an interest rate cap agreements with MUFG Union Bank, N.A. to cap floating interest rates at 2.00%. The purpose of the interest rate cap agreement is to protect the Fund against rising interest rates, as the Fund originates loans with fixed interest rates. The Fund continues to adjust the notional principal amount as the outstanding balance under the debt facility changes. As of September 30, 2017, the Fund had four interest cap contracts with the notional principal amount of $87.0 million. The Fund paid initial costs for the cap agreements of $113,400, which are amortized on a straight- line basis over the life of the instruments. It will receive counterparty payment when the 90-day LIBOR rate exceeds the 2.00% cap rate on each settlement date, which as of September 30, 2017 was 1.3339%. Payments, if necessary, would be made quarterly and would terminate on April 5, 2019.
The average notional amount outstanding was $87.0 million and $0.2 million for the three months ended September 30, 2017 and 2016, respectively. The average notional amount outstanding was $61.0 million for and less than $0.1 million for the nine months ended September 30, 2017 and 2016, respectively.
As of September 30, 2017 and December 31, 2016, the fair value of the Fund’s derivative financial instruments was as follows:
Asset Derivatives | ||||||||||||
September 30, 2017 | December 31, 2016 | |||||||||||
Derivatives: | Location on Condensed Statement of Assets and Liabilities | Fair Value | Location on Condensed Statements of Assets and Liabilities | Fair Value | ||||||||
Interest rate cap agreement | Interest Rate Cap | $ | 45,901 | Interest Rate Cap | $ | 117,849 |
25
For the three and nine months ended September 30, 2017 and 2016, the derivative financial instruments had the following effect on the Condensed Statements of Operations:
Asset Derivatives | ||||||||||
For the Three Months Ended | ||||||||||
Derivatives: | Location on Condensed Statement of Operations | September 30, 2017 | September 30, 2016 | |||||||
Interest rate cap agreement | Net change in unrealized gain (loss) from investments | $ | 289 | $ | (10,913 | ) | ||||
For the Nine Months Ended | ||||||||||
Derivatives: | Locations on Condensed statements of operations | September 30, 2017 | September 30, 2016 | |||||||
Interest rate cap agreement | Net change in unrealized loss from investments | $ | (94,671 | ) | $ | (10,913 | ) |
9. Tax Status
The Fund has elected to be treated as a Regulated Investment Company (“RIC”) under Subchapter M of the Internal Revenue Code (the “Code”) and operates in a manner to qualify for the tax treatment applicable to RICs. Failing to maintain at least 70% of total assets in “qualifying assets” will result in the loss of BDC status, resulting in losing its favorable tax treatment as a RIC. As of September 30, 2017, the Fund has met the BDC and RIC requirements.
To qualify for favorable tax treatment as a RIC, the Fund is required to distribute annually to its sole shareholder at least 90% of its investment company taxable income, as defined by the Code. To avoid federal excise taxes, the Fund must distribute annually at least 98% of its ordinary income and 98.2% of net capital gains from the current year and any undistributed ordinary income and net capital gains from the preceding years. The Fund, at its discretion, may carry forward taxable income in excess of calendar year distributions and pay a 4% excise tax on this income. If the Fund chooses to do so, all other things being equal, this would increase expenses and reduce the amount available to be distributed to the sole shareholder. The Fund will accrue excise tax on estimated undistributed taxable income as required. Below is a table summarizing the cost (on GAAP and tax basis) and the appreciation and depreciation of the investments reported on the Schedule of Investments in Note 3.
As of September 30, 2017
Asset | Cost | Unrealized Appreciation | Unrealized Depreciation | Net Appreciation (Depreciation) | Fair Value | ||||||||||
Loans | 288,624,300 | $ | — | (2,271,601 | ) | $ | (2,271,601 | ) | $ | 286,352,699 | |||||
Interest Rate Cap | $ | 80,529 | $ | (34,628 | ) | $ | (34,628 | ) | $ | 45,901 | |||||
Total | $ | 288,704,829 | $ | — | $ | (2,306,229 | ) | $ | (2,306,229 | ) | $ | 286,398,600 |
As of December 31, 2016
Asset | Cost | Unrealized Appreciation | Unrealized Depreciation | Net Appreciation (Depreciation) | Fair Value | ||||||||||
Loans | $ | 128,866,570 | $ | — | $ | (3,315,913 | ) | $ | (3,315,913 | ) | $ | 125,550,657 | |||
Interest Rate Cap | $ | 57,806 | $ | 60,043 | $ | — | $ | 60,043 | $ | 117,849 | |||||
Total | $ | 128,924,376 | $ | 60,043 | $ | (3,315,913 | ) | $ | (3,255,870 | ) | $ | 125,668,506 |
26
Dividends from net investment income and distributions from net realized capital gains are determined in accordance with U.S. federal income tax regulations, which may differ from those amounts determined in accordance with GAAP. These book/tax differences are either temporary or permanent in nature. To the extent these differences are permanent, they are charged or credited to paid-in-capital or accumulated net realized gain (loss), as appropriate, in the period that the differences arise. Temporary and permanent differences are primarily attributable to differences in the tax treatment of certain loans and the tax characterization of income and non-deductible expenses. These differences are generally determined in conjunction with the preparation of the Fund’s annual RIC tax return.
Book and tax basis differences relating to shareholder dividends and distributions and other permanent book and tax differences are reclassified among the Fund’s capital accounts. In addition, the character of income and gains to be distributed is determined in accordance with income tax regulations that may differ from GAAP.
Through September 30, 2017, the Fund had no undistributed earnings. Additionally, for the nine months ended September 30, 2017, total distributions made exceeded distributable earnings by approximately $5.8 million. The Fund has the discretion to pay distributions in excess of its taxable net investment income. This excess would be a tax-free return of capital in the period and reduce the shareholder’s tax basis in its shares and no uncertain tax positions. As of September 30, 2017, the Fund had no capital loss carry forwards.
The Fund’s tax years are open to examination by federal tax authorities and California tax authorities for the years 2015 and forward.
10. FINANCIAL HIGHLIGHTS
GAAP requires disclosure of financial highlights of the Fund for the three and nine months ended September 30, 2017 and 2016. The total rate of return is defined as the return based on the change in value during the period of a theoretical investment made at the beginning of the period. The total rate of return assumes a constant rate of return for the Fund during the period reported and weights each cash flow by the amount of time held in the Fund. This required methodology differs from an internal rate of return.
The ratios of expenses and net investment income (loss) to average net assets, calculated below, are annualized and are computed based upon the aggregate weighted average net assets of the Fund for the periods presented. Net investment income (loss) is inclusive of all investment income net of expenses, and excludes realized or unrealized gains and losses.
Beginning and ending net asset values per share are based on the beginning and ending number of shares outstanding. Other per share information is calculated based upon the aggregate weighted average net assets of the Fund for the periods presented.
27
The following per share data and ratios have been derived from the information provided in the financial statements:
For the Three Months Ended September 30, 2017 | For the Three Months Ended September 30, 2016 | For the Nine months ended September 30, 2017 | For the Nine Months Ended September 30, 2016 | ||||||||||||
Total return ** | 3.63 | % | (3.08 | )% | 7.42 | % | (6.11 | )% | |||||||
Per share amounts: | |||||||||||||||
Net asset value, beginning of period | $ | 1,247.41 | $ | 625.36 | $ | 810.72 | $ | 320.59 | |||||||
Net investment income gain (loss) | 63.40 | 1.09 | 125.09 | (14.11 | ) | ||||||||||
Net realized and change in unrealized loss from investments | (5.68 | ) | (21.00 | ) | (28.21 | ) | (21.00 | ) | |||||||
Net increase (decrease) in net assets from operations | 57.72 | (19.91 | ) | 96.88 | (35.11 | ) | |||||||||
Distributions of income to shareholder | (58.08 | ) | — | (87.38 | ) | — | |||||||||
Return of capital to shareholder | 23.82 | (12.62 | ) | (58.35 | ) | (51.65 | ) | ||||||||
Contributions from shareholder | 642.50 | 40.00 | 1,151.50 | 399.00 | |||||||||||
Net asset value, end of period | $ | 1,913.37 | $ | 632.83 | $ | 1,913.37 | $ | 632.83 | |||||||
Net assets, end of period | $ | 191,336,744 | $ | 63,283,139 | $ | 191,336,744 | $ | 63,283,139 | |||||||
Ratios to average net assets: | |||||||||||||||
Expenses* | 8.84 | % | 20.12 | % | 11.90 | % | 20.54 | % | |||||||
Net investment income gain (loss)* | 15.27 | % | 0.68 | % | 13.19 | % | (3.20 | )% | |||||||
Portfolio Turn-over rate | 0% | 0% | 0% | 0% | |||||||||||
Average debt outstanding | $ | 114,675,000 | $ | 32,750,000 | $ | 91,170,000 | $ | 22,428,571 | |||||||
* Annualized | |||||||||||||||
**Total return amounts presented above are not annualized. |
11. SUBSEQUENT EVENTS
The Fund evaluated subsequent events through the date the financial statements were issued and determined that no additional subsequent events had occurred that would require accrual or disclosure in the financial statements.
28
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
In addition to the historical information contained herein, the information in this Quarterly Report on Form 10-Q contains certain “forward-looking statements” within the meaning of the securities laws. These forward-looking statements reflect the current view of the Fund with respect to future events and financial performance and are subject to several risks and uncertainties, many of which are beyond the Fund’s control. All statements, other than statements of historical facts included in this report, regarding the strategy, future operations, financial position, estimated revenues, projected costs, prospects, plans and objectives of the Fund are forward-looking statements. When used in this report, the words “will”, “believe”, “anticipate”, “intend”, “estimate”, “expect”, “project” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. All forward-looking statements speak only as of the date of this report. The Fund does not undertake any obligation to update or revise publicly any forward-looking statements, whether resulting from new information, future events or otherwise.
The reader of this Quarterly Report should understand that all such forward-looking statements are subject to various uncertainties and risks that could affect their outcome. The Fund’s actual results could differ materially from those suggested by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, variances in the actual versus projected growth in assets, return on assets, loan losses, expenses, rates charged on loans and earned on securities investments, competition and macro-economic changes including inflation, interest rate expectations, among other factors. This entire Quarterly Report should be read to put such forward-looking statements in context and to gain a more complete understanding of the uncertainties and risks involved in the Fund’s business.
Overview
The Fund is 100% owned by the Company. The Fund’s shares of Common Stock, at $0.001 par value, were sold to its sole shareholder, the Company, under a stock purchase agreement. The Fund has issued 100,000 of the Fund’s 10,000,000 authorized shares. The Company may make additional capital contributions to the Fund.
The Fund is a financial services company providing financing and advisory services to a variety of carefully selected venture-backed companies primarily throughout the United States with a focus on growth oriented companies. The Fund’s portfolio is well diversified and consists of companies in the communications, information services, media, and technology, including software and technology-enabled business services, bio-technology, and medical devices industry sectors, among others. The Fund’s capital is generally used by its portfolio companies to finance acquisitions of fixed assets and working capital. On August 31, 2015, the Fund completed its first closing of capital contributions. On September 1, 2015, the Fund made its first investments, and became a non-diversified, closed-end investment company that elected to be treated as a business development company under the Investment Company Act of 1940. The Fund elected to be treated for federal income tax purposes as a RIC under the Code with the filing of its 2016 tax return. Pursuant to this election, the Fund generally will not have to pay corporate-level taxes on any income it distributes to the Company as dividends, allowing the Company to substantially reduce or eliminate its corporate-level tax liability.
The Fund will seek to meet the ongoing requirements, including the diversification requirements, to qualify as a RIC under the Code. If the Fund fails to meet these requirements, it will be taxed as an ordinary corporation on its taxable income for that year (even if that income is distributed to the Company) and all distributions out of its earnings and profits will be taxable to the Members of the Company as ordinary income; thus, such income will be subject to a double layer of tax. There is no assurance that the Fund will meet the ongoing requirements to qualify as a RIC for tax purposes.
The Fund’s investment objective is to achieve superior risk adjusted investment returns and the Fund seeks to achieve its investment objective by providing debt financing to portfolio companies. Since inception, the Fund’s investing activities have focused primarily on private debt securities. In connection with its portfolio investments, the Fund generally receives warrants to acquire equity securities in connection with its portfolio investments. It is
29
anticipated that such warrants will be distributed by the Fund to the Company simultaneously with, or shortly following, their acquisition. The Fund also has guidelines for the percentages of total assets which will be invested in different types of assets.
The portfolio investments of the Fund will primarily consist of debt financing to venture capital backed technology companies. The borrower’s ability to repay its loans may be adversely impacted by a variety of factors and, as a result, the loan may not be fully be repaid. Furthermore, the Fund’s security interest in any collateral over the borrower’s assets may be insufficient to make up any shortfall in payments.
Transactions with Venture Lending & Leasing VII, Inc. (“Fund VII”)
The Manager also serves as investment manager for Fund VII, which has now stopped making new investment commitments, but continues to fund its commitment backlog. The Fund will continue to invest in each portfolio company in which Fund VII invests, so long as prior to any such investment, the Board of Directors of Fund VII and the Fund receive a memorandum summarizing the proposed investment and do not object to such investment. The amount of each investment will be allocated between the Fund and Fund VII in accordance with the decisions of their respective Board of Directors.
To the extent that clients, other than Fund VII, advised by the Manager (but in which the Manager has no proprietary interest) invest in opportunities available to the Fund, the Manager will allocate such opportunities among the Fund and such other clients in a manner deemed fair and equitable considering all the circumstances in accordance with procedures approved by the Fund’s Board (including a majority of the disinterested directors).
Critical Accounting Policies
Critical Accounting Policies and Practices are those accounting policies and practices that are both the most important to the portrayal of the Fund’s net assets and results of operations and require the most difficult, subjective or complex judgments, often because of the need to make estimates about the effect of matters that are inherently uncertain. Critical accounting estimates are accounting estimates where the nature of the estimates are material due to the levels of subjectivity and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change and the impact of the estimates on net assets or operating performance is material.
In evaluating the most critical accounting policies and estimates, the Manager has identified the estimation of fair value of the Fund’s loan investments as the most critical of the accounting policies and accounting estimates applied to the Fund’s reporting of net assets or operating performance. In accordance with GAAP, the Fund defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date; that is, an exit price. The exit price assumes the asset or liability was exchanged in an orderly transaction; it was not a forced liquidation or distressed sale. There is no secondary market for the loans made by the Fund to borrowers, hence Management determines fair value based on hypothetical market and the estimates are subject to high levels of judgment and uncertainty. The Fund’s loan investments are considered Level 3 fair value measurements in the fair value hierarchy due to the lack of observability over many of the important inputs used in determining fair value.
Critical judgments and inputs in determining the fair value of a loan include payment history, available cash and “burn rate,” revenues, net income or loss, operating results, financial strength of borrower, prospects for the borrower’s raising future equity rounds, likelihood of sale or acquisition of the borrower, length of expected holding period of the loan, collateral position, the timing and amount of liquidation of collateral for loans that are experiencing significant credit deterioration and collection becomes collateral dependent as well as an evaluation of the general interest rate environment. Management has evaluated these factors and has concluded that the effect of a deterioration in the quality of the underlying collateral, increase in the size of the loan, increase in the estimated time to recovery, and increase in the hypothetical market coupon rate would have the effect of decreasing the fair value of loan investments. The risk profile of a loan changes when events occur that impact the credit analysis of the borrower and the loan. Such changes result in the fair value being adjusted from par value of the individual loan. Where the risk profile is consistent with the original underwriting, the par value of the loan often approximates fair value.
30
The actual value of the loans may differ from management’s estimates, which would affect net change in net assets resulting from operations as well as assets.
Results of Operations - For the three and nine months ended September 30, 2017 and 2016
Total investment income for the three months ended September 30, 2017 and 2016 was $10.0 million and $3.3 million, respectively which primarily consisted of interest on the venture loans outstanding. The remaining income consisted of interest and dividends on the temporary investment of cash and forfeited commitment fees and warrants. The income was primarily driven by the level of average loans outstanding for the three months ended September 30, 2017 and 2016 of $259.0 million and $87.3 million, respectively.
Total investment income for the nine months ended September 30, 2017 and 2016 was $23.8 million and $7.7 million, which primarily consisted of interest on the venture loans outstanding. The remaining income consisted of interest and dividends on the temporary investment of cash and forfeited commitment fees and warrants. The income was primarily driven by the level of average loans outstanding for the nine months ended September 30, 2017 and 2016 of $200.6 million and $64.2 million, respectively.
Management fees are calculated based on the Company’s committed capital for the first two years of the Fund’s life and thereafter as a percentage of Fund assets. Management fees were $2.3 million and $2.6 million for the three months ended September 30, 2017 and 2016. Until August 11, 2017, management fees were calculated as 2.5 percent of the committed capital of the Company. Starting on August 12, 2017, management fees were calculated as 2.5 percent of the Fund’s total assets.
Management fees are calculated based on the Company’s committed capital for the first two years of the Fund’s life and thereafter as a percentage of Fund assets. Management fees were $7.5 million for the nine months ended September 30, 2017 and $7.9 million for the nine months ended September 30, 2016. Until August 11, 2017, management fees were calculated as 2.5 percent of the committed capital of the Company. Starting on August 12, 2017, management fees were calculated as 2.5 percent of the Fund’s total assets.
Interest expense was $1.3 million and $0.5 million for the three months ended September 30, 2017 and 2016, respectively. Interest expense was comprised of amounts related to interest on debt amounts drawn down, unused line fees and amounts amortized from deferred fees incurred in conjunction with the debt line. Interest expenses increased primarily due to an increase in average outstanding debt from $32.8 million in 2016 to $114.7 million in 2017.
Interest expense was $3.1 million and $0.9 million for the nine months ended September 30, 2017 and 2016, respectively. Interest expense was comprised of amounts related to interest on debt amounts drawn down, unused line fees and amounts amortized from deferred fees incurred in conjunction with the debt line. Interest expenses increased primarily due to an increase in average outstanding debt from $22.4 million in 2016 to $91.2 million in 2017.
The banking and professional fees were less than $0.1 million for the three months ended September 30, 2017 and 2016, respectively. The banking and professional fees were comprised of legal, audit, banking and other professional fees.
The banking and professional fees were $0.2 million for the nine months ended September 30, 2017 and 2016, respectively. The banking and professional fees were comprised of legal, audit, banking and other professional fees.
Total other operating expenses were less than $0.1 million for the three months ended September 30, 2017 and 2016, respectively. Operating expenses decreased due to the absence of the expenses associated with the liquidation of certain portfolio investments compared to prior quarter.
Total other operating expenses were $0.4 million and less than $0.1 million for the nine months ended September 30, 2017 and 2016, respectively. Operating expenses increased due to the increase in expenses associated with the liquidation of certain portfolio investments compared to prior quarter.
31
Net investment income for the three months ended September 30, 2017 and 2016, was $6.3 million and $0.1 million, respectively.
Net investment income (loss) for the nine months ended September 30, 2017 and 2016, was $12.5 million and $(1.4) million, respectively.
Total net realized loss from investments was $0.5 million and $0 for the three months ended September 30, 2017 and 2016, respectively.
Total net realized loss from investments was $3.8 million and $0 for the nine months ended September 30, 2017 and 2016, respectively.
Net change in unrealized loss from investments was less than $0.1 million and $2.1 million for the three months ended September 30, 2017 and 2016, respectively. The unrealized loss consists of fair market value adjustments to loans and interest rate cap.
Net change in unrealized gain (loss) from investments was $0.9 million and $(2.1) million for the nine months ended September 30, 2017 and 2016, respectively. The unrealized loss consists of fair market value adjustments to loans and interest rate cap.
Net increase (decrease) in net assets resulting from operations for the three months ended September 30, 2017 and 2016, was $5.8 million and $(2.0) million, respectively. On a per share basis, the net decrease in net assets resulting from operations was $57.72 and $(19.91), respectively.
Net increase (decrease) in net assets resulting from operations for the nine months ended September 30, 2017 and 2016, was $9.7 million and $(3.5) million, respectively. On a per share basis, the net decrease in net assets resulting from operations was $96.88 and $(35.11), respectively.
Liquidity and Capital Resources – September 30, 2017 and December 31, 2016
Total capital contributed to the Fund was $213.1 million and $97.9 million as of September 30, 2017 and December 31, 2016, respectively. Committed capital to the Company as of September 30, 2017 and December 31, 2016 was $423.6 million, of which $249.9 million and $116.5 million had been called as of September 30, 2017 and December 31, 2016, respectively. The remaining $173.7 million of committed capital outstanding as of September 30, 2017 expires on the Fund’s fifth anniversary, August 20, 2020 after which time no further capital can be called. However, the Management is permitted to extend the Fund’s investment period by up to two (2) additional calendar quarters in its sole and absolute discretion.
On April 5, 2016, the Fund established the “Loan Agreement” led by Wells Fargo Bank, N.A. and MUFG Union Bank, N.A. in an initial amount of up to $150,000,000. On September 11, 2017, the Loan Agreement was amendmend (the “Amended Loan Agreement”). In September 2017, the borrowing availability thereunder was increased to $280,000,000. Borrowings by the Fund are collateralized by all the assets of the Fund. Loans under the facility may be, at the option of the Fund, a Reference Rate Loan, a LIBOR Rate Loan, or a LIBOR Market Index Rate Loan. The Fund will pay interest on its borrowings, and will also pay a fee on the unused portion of the facility.
The facility terminates on September 11, 2020, but can be accelerated in the event of default, such as failure by the Fund to make timely interest or principal payments. As of September 30, 2017, $113.0 million is outstanding under the facility.
As of September 30, 2017 and December 31, 2016, 5.0% and 7.1%, respectively, of the Fund’s assets consisted of cash and cash equivalents. For the nine months ended September 30, 2017, the Fund invested its assets in entirely
32
in venture loans and disbursed under the Fund’s loan commitments approximately $209.7 million. Net loan amounts outstanding after amortization increased by approximately $160.8 million for the same period. Unexpired, unfunded commitments totaled approximately $75.1 million as of September 30, 2017.
As of | Cumulative Amount Disbursed | Principal Reductions and Fair Market Adjustments | Balance Outstanding - Fair Value | Unexpired Unfunded Commitments |
September 30, 2017 | $352.5 million | $66.1 million | $286.4 million | $75.1 million |
December 31, 2016 | $142.8 million | $17.2 million | $125.6 million | $53.4 million |
Because venture loans are privately negotiated transactions, investments in these assets are relatively illiquid. It is the Management’s experience that not all unfunded commitments will be used by borrowers.
The Fund seeks to meet the requirements to qualify for the special pass-through status available to RICs under the Code, and thus to be relieved of federal income tax on that part of its net investment income and realized capital gains that it distributes to its shareholder. To qualify as a RIC, the Fund must distribute to its shareholder for each taxable year at least 90% of its investment company taxable income (consisting generally of net investment income and net short-term capital gain) (“Distribution Requirement”). To the extent that the terms of the Fund’s venture loans provide for the receipt by the Fund of additional interest at the end of the loan term or provide for the receipt by the Fund of a purchase price for the asset at the end of the loan term (“residual income”), the Fund would be required to accrue such residual income over the life of the loan, and to include such accrued undistributed income in its gross income for each taxable year even if it receives no portion of such residual income in that year. Thus, in order to meet the Distribution Requirement and avoid payment of income taxes or an excise tax on undistributed income, the Fund may be required in a particular year to distribute as a dividend an amount in excess of the total amount of income it actually receives. Those distributions will be made from the Fund’s cash assets, from amounts received through amortization of loans or from borrowed funds.
As of September 30, 2017, the Fund has adequate cash reserves of $15.4 million and approximately $91.9 million in scheduled receivable payments over the next twelve months. Additionally the Fund has access to uncalled capital of $173.7 million as a liquidity source and the unused portion of the revolving credit facility. These amounts are sufficient to meet the current commitment backlog and operational expenses of the next year. The Fund regularly evaluates potential future liquidity resources and demands before making additional future commitments.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
The Fund’s business activities contain elements of risk of which Management considers interest rate and credit risk to be the principal types of risk. Because the Fund considers the management of risk essential to conducting its business and to maintaining profitability, the Fund’s risk management procedures are designed to identify and analyze the Fund’s risks, to set appropriate policies and limits and to continually monitor these risks and limits by means of reliable administrative and information systems and other policies and programs.
The Fund manages its market risk by maintaining a portfolio that is diverse by industry, size of investment, stage of development, and borrower. The Fund has limited exposure to public market price fluctuations as the Fund primarily invests in private business enterprises and distributes all equity investments upon receipt to the Company.
The Fund’s investments are subject to market risk based on several factors, including, but not limited to, the borrower’s credit history, available cash, support of the borrower’s underlying investors, available liquidity, “burn rate”, revenue income, security interest, secondary markets for collateral, the size of the loan, and term of the loan, and the ability to exit via Initial Public Offering or Merger and Acquisition.
The Fund’s exposure to interest rate sensitivity is regularly monitored and analyzed by measuring the characteristics of assets and liabilities. The Fund utilizes various methods to assess interest rate risk in terms of the
33
potential effect on interest income net of interest expense, the value of net assets and the value at risk in an effort to ensure that the Fund is insulated from any significant adverse effects from changes in interest rates. At September 30, 2017, the outstanding debt balance was $113.0 million with interest expense based on a weighted average rate of 1.31%, for which the Fund had an interest rate cap in place at 2.00% on $87.0 million of outstanding debt, leaving the Fund’s maximum exposure to interest rate sensitivity at 0.69% on the capped position of the outstanding debt balance, which the Manager does not believe is material to the financial statements. The Fund has no interest rate protection for the remaining $26.0 million uncapped portion.
Because the Fund’s loans all impose a fixed interest rate upon funding, changes in short-term interest rates will not directly affect interest income associated with the loan portfolio as of September 30, 2017. However, those changes could have the potential to change the Fund’s ability to originate loan commitments, acquire and renew bank facilities, and engage in other investment activities. Further, changes in short-term interest rates also could affect interest rate expense, realized gain from investments and interest on the Fund’s short-term investments.
Based on the Fund’s Condensed Statement of Assets and Liabilities as of September 30, 2017, the following table shows the approximate annualized increase (decrease) in components of net assets resulting from operations of hypothetical base rate changes in interest rates, assuming no changes in investments, borrowings, cash balances, and interest rate hedges.
Effect of Interest rate change by | Other Interest and Other Income/(Loss) | Realized Gain on the Cap | Interest Income/(Expense) | Total Income/(Loss) | |||||||
(0.50)% | $ | (76,769 | ) | — | $ | 565,000 | $ | 488,231 | |||
1% | $ | 153,537 | 273,781 | $ | (1,130,000 | ) | $ | (702,682 | ) | ||
2% | $ | 307,075 | 1,143,781 | $ | (2,260,000 | ) | $ | (809,145 | ) | ||
3% | $ | 460,612 | 2,013,781 | $ | (3,390,000 | ) | $ | (915,608 | ) | ||
4% | $ | 614,149 | 2,883,781 | $ | (4,520,000 | ) | $ | (1,022,070 | ) | ||
5% | $ | 767,686 | 3,753,781 | $ | (5,650,000 | ) | $ | (1,128,533 | ) |
Additionally, a change in the interest rate may affect the value of the interest rate cap and effect Net Change in Unrealized Gain (Loss) from investment. The amount of any such effect will be contingent upon market expectations for future interest rate changes. Any increases in expected future rates will increase the value of the interest rate cap while any rate decreases will decrease the value.
Although Management believes that the foregoing analysis is indicative of the Fund’s sensitivity to interest rate changes, it does not take into consideration potential changes in the credit market, credit quality, size and composition of the assets in the portfolio. It also does not assume any new fundings to borrowers, repayments from borrowers or defaults on borrowings. Accordingly, no assurances can be given that actual results would not differ materially from the table above.
Because the Fund currently borrows, its net investment income is highly dependent upon the difference between the rate at which it borrows and the rate at which it invests the amounts borrowed. Accordingly, there can be no assurance that a significant change in market interest rates will not have a material adverse effect on the Fund’s investment activities and net investment income. The Fund’s exposure to movement in short-term interest rates stems from the Fund borrowing at a floating interest rate but then making loans with a fixed rate at the time the loans are extended. The Fund, therefore, attempts to limit its interest rate risk by acquiring interest rate caps, and anticipates hedging interest rate risk associated with future borrowings.
34
Item 4. Controls and Procedures:
Evaluation of Disclosure Controls and Procedures:
As of the end of the period covered by this quarterly report on Form 10-Q, the Fund’s chief executive officer and chief financial officer conducted an evaluation of the Fund’s disclosure controls and procedures (as defined in Rules 13a-15 and 15d-15 of the Securities Exchange Act of 1934). Based upon this evaluation, the Fund’s chief executive officer and chief financial officer concluded that the Fund’s disclosure controls and procedures were effective in timely alerting them of any material information relating to the Fund that is required to be disclosed by the Fund in the reports it files or submits under the Securities Exchange Act of 1934.
Changes in Internal Controls:
There were no material changes in the Fund’s internal controls or in other factors that could materially affect these controls during the period covered by this quarterly report on Form 10-Q.
PART II — OTHER INFORMATION
Item 1. Legal Proceedings
The Fund may become party to certain lawsuits from time to time in the normal course of business. While the outcome of any legal proceedings cannot now be predicted with certainty, the Fund does not expect any such proceedings will have a material effect upon the Fund’s financial condition or results of operation. Management is not aware of any pending legal proceedings involving the Fund.
Item 1A. Risk Factors
See item 1A - “Risk Factors”’ in the Fund’s 2016 Annual Report on Form 10-K for a detailed description of the risks attendant to the Fund and its business. There were no material changes to these factors during the three and nine months ended September 30, 2017.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Prior to the Fund’s commencement of operations on August 12, 2015, the Fund sold 100,000 shares to the Fund’s sole shareholder, the Company, for $25,000 in July 2015. No other shares of the Fund have been sold; however, the Fund received an additional $213.1 million of paid in capital during the period from August 12, 2015, commencement of operations, through September 30, 2017, which is expected to be used to acquire venture loans and fund operations.
Item 3. Defaults Upon Senior Securities
Not applicable.
Item 4. Mine Safety Issues
Not applicable.
35
Item 5. Other Information
None.
Item 6. Exhibits
Exhibit Number | Description |
3(i) | |
3(ii) | |
4.1 | |
31.1 | |
31.2 | |
32.1 | |
32.2 |
36
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned duly authorized.
VENTURE LENDING & LEASING VIII, INC.
(Registrant)
By: | /s/ Maurice C. Werdegar | By: | /s/ Martin D. Eng |
Maurice C. Werdegar | Martin D. Eng | ||
President and Chief Executive Officer | Chief Financial Officer | ||
Date: | November 13, 2017 | Date: | November 13, 2017 |
37
EXHIBIT INDEX
Exhibit Number | Description |
31.1-32.2 | Certifications pursuant to The Sarbanes-Oxley Act of 2002. |
38